Nonclinical Assessment of Abuse Potential for New Pharmaceuticals

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Reference & Language, Law, International
Cover of the book Nonclinical Assessment of Abuse Potential for New Pharmaceuticals by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780124202160
Publisher: Elsevier Science Publication: July 14, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780124202160
Publisher: Elsevier Science
Publication: July 14, 2015
Imprint: Academic Press
Language: English

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

  • Provides a consolidated overview of the complex regulatory landscape
  • Offers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies
  • Includes real-life examples to illustrate how nonclinical data fit into the submission strategy
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

More books from Elsevier Science

Cover of the book Computational Systems Biology by
Cover of the book Physiological Systems in Insects by
Cover of the book Workplace Culture in Academic Libraries by
Cover of the book Energy and Sea Power by
Cover of the book Stand-Alone and Hybrid Wind Energy Systems by
Cover of the book Reaction Kinetics by
Cover of the book Progress in Medicinal Chemistry by
Cover of the book Histone Deacetylase Inhibitors as Cancer Therapeutics by
Cover of the book Theory of Simple Liquids by
Cover of the book Hydroxyapatite (HAp) for Biomedical Applications by
Cover of the book Business Continuity State of the Industry Report by
Cover of the book Principles of Addiction by
Cover of the book Computational Fluid Dynamics by
Cover of the book Handbook of Frontier Markets by
Cover of the book Single Molecule Tools, Part B: Super-Resolution, Particle Tracking, Multiparameter, and Force Based Methods by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy